Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy

Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype Differentiation

(2022) Johanna S. Enke et al.   Cancers

Automated detection and segmentation of thoracic lymph nodes from CT using 3D foveal fully convolutional neural networks

(2021) Andra-Iza Iuga et al.   BMC MEDICAL IMAGING

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy

(2021) Claudia Trojaniello et al.   Frontiers in Oncology

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach

(2021) Antonino Guerrisi et al.   Frontiers in Oncology

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review

(2020) Antonino Guerrisi et al.   Cancer Medicine

Radiomics, tumor volume and blood biomarkers for early prediction of pseudoprogression in metastatic melanoma patients treated with immune checkpoint inhibition

(2020) Lucas Basler et al.   CLINICAL CANCER RESEARCH

The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping

(2020) Alex Zwanenburg et al.   RADIOLOGY

Pilot Study of CT-Based Radiomics Model for Early Evaluation of Response to Immunotherapy in Patients With Metastatic Melanoma

(2020) Zhi-long Wang et al.   Frontiers in Oncology

nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation

(2020) Fabian Isensee et al.   NATURE METHODS

Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab

(2019) Carole Durot et al.   EUROPEAN RADIOLOGY

Splitting on categorical predictors in random forests

(2019) Marvin N. Wright et al.   PeerJ

Predicting Response to Cancer Immunotherapy using Non-invasive Radiomic Biomarkers

(2019) S Trebeschi et al.   ANNALS OF ONCOLOGY

Assessing Radiology Research on Artificial Intelligence: A Brief Guide for Authors, Reviewers, and Readers—From the Radiology Editorial Board

(2019) David A. Bluemke et al.   RADIOLOGY

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

(2018) Reinhard Dummer et al.   LANCET ONCOLOGY

Bootstrapping the out-of-sample predictions for efficient and accurate cross-validation

(2018) Ioannis Tsamardinos et al.   MACHINE LEARNING

Radiomics of CT Features May Be Nonreproducible and Redundant: Influence of CT Acquisition Parameters

(2018) Roberto Berenguer et al.   RADIOLOGY

Melanoma

(2018) Dirk Schadendorf et al.   LANCET

Health-related quality of life results from the phase III CheckMate 067 study

(2017) Dirk Schadendorf et al.   EUROPEAN JOURNAL OF CANCER

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

(2017) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges

(2017) Meghan G. Lubner et al.   RADIOGRAPHICS

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

(2016) S Diem et al.   BRITISH JOURNAL OF CANCER

Applications and limitations of radiomics

(2016) Stephen S F Yip et al.   PHYSICS IN MEDICINE AND BIOLOGY

Predicting Overall Survival in Patients With Metastatic Melanoma on Antiangiogenic Therapy and RECIST Stable Disease on Initial Posttherapy Images Using CT Texture Analysis

(2015) Andrew D. Smith et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Prognostic score for patients with advanced melanoma treated with ipilimumab

(2015) Stefan Diem et al.   EUROPEAN JOURNAL OF CANCER

Measuring Computed Tomography Scanner Variability of Radiomics Features

(2015) Dennis Mackin et al.   INVESTIGATIVE RADIOLOGY

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

(2015) Dirk Schadendorf et al.   JOURNAL OF CLINICAL ONCOLOGY

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

(2015) Georgina V Long et al.   LANCET

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Machine learning applications in cancer prognosis and prediction

(2015) Konstantina Kourou et al.   Computational and Structural Biotechnology Journal

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

(2014) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE